Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price traded up 8.2% during mid-day trading on Monday . The stock traded as high as $1.62 and last traded at $1.54. 119,050 shares were traded during mid-day trading, a decline of 81% from the average session volume of 630,615 shares. The stock had previously closed at $1.42.
Curaleaf Stock Performance
The company has a market cap of $1.33 billion, a PE ratio of -6.22 and a beta of 0.69. The company has a current ratio of 1.41, a quick ratio of 0.70 and a debt-to-equity ratio of 1.08. The business's 50 day moving average is $1.05 and its two-hundred day moving average is $1.05.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.41%. On average, equities research analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.